Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine Patch vs IV Lidocaine for Pain After Cesarean Section
NCT04505644Unknown
- Sponsor
- Aswan University Hospital
- Start
- Sep 2020
- Primary completion
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of Lidocaine Hydrochloride Injection, without epinephrine in postoperative pain and postoperative ileus (POI) (3 arms), sponsored by Aswan University Hospital. Primary endpoints: Total dose of opioids received at 24 hours and Post-operative pain score at 24 hours. Status: unknown.
02
Drugs
Lidocaine Hydrochloride Injection, without epinephrine
03
Conditions
postoperative painpostoperative ileus (POI)
Beyond the preview
Go deeper on NCT04505644.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04505644.